Show simple item record

dc.contributor.authorSchneider, Christian K
dc.contributor.authorVleminckx, Camille
dc.contributor.authorGravanis, Iordanis
dc.contributor.authorEhmann, Falk
dc.contributor.authorTrouvin, Jean-Hugues
dc.contributor.authorWeise, Martina
dc.contributor.authorThirstrup, Steffen
dc.date.accessioned2013-03-13T14:45:49Z
dc.date.available2013-03-13T14:45:49Z
dc.date.issued2012-12
dc.identifier.citationSetting the stage for biosimilar monoclonal antibodies. 2012, 30 (12):1179-85 Nat. Biotechnol.en_GB
dc.identifier.issn1546-1696
dc.identifier.pmid23222783
dc.identifier.doi10.1038/nbt.2447
dc.identifier.urihttp://hdl.handle.net/10033/272043
dc.language.isoenen
dc.rightsArchived with thanks to Nature biotechnologyen_GB
dc.titleSetting the stage for biosimilar monoclonal antibodies.en
dc.typeArticleen
dc.contributor.departmentDanish Health and Medicines Authority, Copenhagen, Denmark. c_schneid@web.deen_GB
dc.identifier.journalNature biotechnologyen_GB
refterms.dateFOA2013-06-15T00:00:00Z


Files in this item

Thumbnail
Name:
Schneider et al_final(3).pdf
Size:
189.5Kb
Format:
PDF
Description:
original manuscript
Thumbnail
Name:
2012_nbt_schneider et al_setting ...
Size:
379.8Kb
Format:
PDF
Description:
figures

This item appears in the following Collection(s)

Show simple item record